EKSO BIONICS HOLDINGS, INC. – Trademark Portfolio
Entity Type: 03
EKSO BIONICS HOLDINGS, INC. has 7 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 are successfully registered — a 43% registration rate. The portfolio includes marks such as NOMAD and INDEGO. Filings span 3 Nice Classification classes, with the highest activity in Class 9 (Computers & Electronics) and Class 42 (Computer & Scientific). This trademark owner is based in San Rafael, CA.
Suite A
101 Glacier Point
San Rafael, CA 94901
Showing of trademarks Trademarks
Trademark Classifications
EKSO BIONICS HOLDINGS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does EKSO BIONICS HOLDINGS, INC. have?
EKSO BIONICS HOLDINGS, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 cancelled.
What trademark classes does EKSO BIONICS HOLDINGS, INC. file in?
EKSO BIONICS HOLDINGS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are EKSO BIONICS HOLDINGS, INC.'s most well-known trademarks?
EKSO BIONICS HOLDINGS, INC.'s registered trademark portfolio includes well-known marks such as NOMAD and INDEGO. These are among 3 currently registered trademarks in the portfolio.
What is EKSO BIONICS HOLDINGS, INC.'s trademark registration success rate?
EKSO BIONICS HOLDINGS, INC. has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.